Search for: "Merck & Co., Inc. v. Mylan Pharmaceuticals, Inc."
Results 21 - 40
of 44
Sorted by Relevance
|
Sort by Date
13 Oct 2016, 6:50 am
Lee, No. 16-446 (Eligibility of new use of old manufacture – blackjack game) Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
15 Apr 2011, 6:02 am
Mylan Pharmaceuticals, Inc., 2009 WL 7115134, at *2 (N.D. [read post]
8 Feb 2017, 3:09 am
Alfonso Cioffi, No. 16-200 (holding prosecution history against the patentee) Civil Procedure – Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
16 Jan 2017, 5:44 pm
Alfonso Cioffi, No. 16-200 (holding prosecution history against the patentee) Civil Procedure – Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
6 Mar 2014, 12:41 pm
Pfizer, Inc., 490 F. [read post]
6 Apr 2011, 12:18 am
Highlights this week included: India firm on ‘NO’ to data exclusivity (SiNApSE) (Generic Pharmaceuticals and IP) (Spicy IP) (Spicy IP) US: CAFC hears oral arguments on patentability of DNA claims: American Molecular Pathology, et. al, v. [read post]
9 Mar 2011, 3:00 am
Highlights this week included: Supreme Court shuts another door on patent settlement agreement antitrust challenge – denies certiorari in Cipro case: Louisiana Wholesale Drug Co. v. [read post]
2 Sep 2009, 11:22 pm
Fujisawa Pharmaceutical Co., 464 F. [read post]
9 Aug 2012, 5:00 am
Nittany Pharmaceuticals (?) [read post]
17 Feb 2010, 5:10 am
USA, Inc; Eli Lilly & Co. v. [read post]
2 Mar 2012, 6:52 am
Merck (Vioxx) Trial2006-05-08 Doherty v. [read post]
28 Jun 2007, 10:16 am
Merck & Co., 894 A.2d 1136 (N.J. [read post]
9 Nov 2015, 7:39 am
Merck Sharp & Dohme v Ono Pharmaceutical [2015] EWHC 2973 (Pat), decided on 22 October by Mr Justice Birss in the Patents Court, England and Wales, is a decidedly unbifurcated ruling, being a full-blooded infringement-and-invalidity action running to 243 paragraphs. [read post]
3 Feb 2011, 2:11 pm
Mylan Pharmaceuticals., Inc., 696 F. [read post]
22 Feb 2008, 6:00 pm
Signature Financial Group, Inc., and AT&T Corp. v. [read post]
28 Oct 2011, 7:00 am
Mylan Pharmaceuticals, Inc., 751 F. [read post]
28 Apr 2011, 3:18 pm
Brown v. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
6 Jun 2008, 6:49 am
: (Spicy IP) Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
